Evidence map›Paper›PMID 22069257›Full record

ArticleDiabetes/metabolism research and reviews2011

Imaging the pancreatic vasculature in diabetes models.

Zdravka Medarova, Dale L Greiner, Marytheresa Ifediba, Guangping Dai, Elijah Bolotin, Gerardo Castillo, Alexei Bogdanov, Mohanraja Kumar, Anna Moore

Abstract read
In one paragraph

Article in Diabetes/metabolism research and reviews, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Imaging NF-κB activity in a murine model of early stage diabetes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Zdravka MedarovaMolecular Imaging Laboratory, Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Dale L Greiner
Marytheresa Ifediba
Guangping Dai
Elijah Bolotin
Gerardo Castillo
Alexei Bogdanov
Mohanraja Kumar
Anna Moore
Harvard University · USPharmaIN (United States) · USUniversity of Massachusetts Chan Medical School · USMassachusetts General Hospital · US

Funding

PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
Molecular Mechanisms of Human and Murine Beta Cell Proliferation and RegenerationU01DK089572 · NIDDK · VANDERBILT UNIVERSITY · PI GREINER, DALE LESLIE, HARLAN, DAVID MARSHALL · 2010 to 2014
$8.4M
Long Acting Native GLP-1 formulations for Type 1 DiabetesR44DK069727 · NIDDK · PHARMAIN CORPORATION · PI BOLOTIN, ELIJAH M. · 2007 to 2009
$3.0M
Targeted formulations of GLP -1 for Type 1 diabetesR43DK069727 · NIDDK · PHARMAIN CORPORATION · PI BOLOTIN, ELIJAH M · 2004 to 2005
$1.0M
Imaging of Pancreatic Islet Vasculature: An Interdisciplinary ResourceR24DK080264 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MOORE, ANNA · 2007 to 2007
$635k
NIDDK NIH HHS DK069727NIDDK NIH HHS DK080264NIDDK NIH HHS DK089572NIDDK NIH HHS DK32520NIDDK NIH HHS P30 DK032520NIDDK NIH HHS R24 DK080264NIDDK NIH HHS R43 DK069727NIDDK NIH HHS R44 DK069727NIDDK NIH HHS U01 DK089572
6 · The paper itself

Abstract

backgroundVascular parameters, such as vascular volume, flow, and permeability, are important disease biomarkers for both type 1 and type 2 diabetes. Therefore, it is essential to develop approaches to monitor the changes in pancreatic microvasculature non-invasively.

methodsHere, we describe the application of the long-circulating, paramagnetic T1 contrast agent, protected Graft Copolymer bearing covalently linked gadolinium diethylenetriaminepentaacetic acid residues and labelled with fluorescein (PGC-GdDTPA-F) for the non-invasive semi-quantitative evaluation of vascular changes in diabetic models using magnetic resonance imaging.

resultsWe observed a significantly higher accumulation of protected graft copolymer bearing covalently linked gadolinium diethylenetriaminepentaacetic acid residues and labelled with fluorescein in the pancreata of BBDR rats induced to develop diabetes, as compared to non-diabetic controls at 1 h post-injection. No differences were seen in the blood pool, kidney, or muscle, indicating that the effect is specific to the diabetic pancreas. Fluorescence microscopy revealed a marked increase in contrast agent availability in the pancreas with the development of the pathology. Similar changes were noted in the homozygous Leprdb mouse model of type 2 diabetes. This effect appeared to result both from the increase of vascular volume and permeability.

conclusionsHigh-molecular weight paramagnetic blood volume contrast agents are valuable for the in vivo definition of pancreatic microvasculature dynamics by magnetic resonance imaging. The increase in vascular volume and permeability, associated with diabetic inflammation, can be monitored non-invasively and semi-quantitatively by magnetic resonance imaging in diabetic BBDR rats. This imaging strategy represents a valuable research tool for better understanding of the pathologic process.

Indexed as

AnimalsDiabetes Mellitus, ExperimentalFluorescein-5-isothiocyanateGadolinium DTPAMagnetic Resonance ImagingMicePancreasRatsFluorescein-5-isothiocyanateGadolinium DTPA

Identifiers

PMID22069257
PMCPMC3721374
OpenAlexW2045715440

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.